Literature DB >> 26502379

Pneumococcal Prevention Gets Older and Wiser.

Anne Schuchat1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26502379      PMCID： PMC5729895          DOI： 10.1001/jamainternmed.2015.6133

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  8 in total

1.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Authors:  Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-07-14       Impact factor: 91.245

2.  Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

Authors:  Marc J M Bonten; Susanne M Huijts; Marieke Bolkenbaas; Chris Webber; Scott Patterson; Samantha Gault; Cornelis H van Werkhoven; Anna M M van Deursen; Elisabeth A M Sanders; Theo J M Verheij; Michael Patton; Anne McDonough; Anita Moradoghli-Haftvani; Helen Smith; Tracey Mellelieu; Michael W Pride; Graham Crowther; Beate Schmoele-Thoma; Daniel A Scott; Kathrin U Jansen; Rita Lobatto; Bas Oosterman; Nils Visser; Esther Caspers; Andre Smorenburg; Emilio A Emini; William C Gruber; Diederick E Grobbee
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

3.  Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-16       Impact factor: 17.586

4.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

5.  Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Miwako Kobayashi; Nancy M Bennett; Ryan Gierke; Olivia Almendares; Matthew R Moore; Cynthia G Whitney; Tamara Pilishvili
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-09-04       Impact factor: 17.586

6.  U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.

Authors:  Marie R Griffin; Yuwei Zhu; Matthew R Moore; Cynthia G Whitney; Carlos G Grijalva
Journal:  N Engl J Med       Date:  2013-07-11       Impact factor: 91.245

7.  Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

Authors:  Brendan Flannery; Jessie Clippard; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Joshua G Petrie; Huong Q McLean; Edward A Belongia; Manjusha Gaglani; LaShondra Berman; Angie Foust; Wendy Sessions; Swathi N Thaker; Sarah Spencer; Alicia M Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-01-16       Impact factor: 17.586

8.  Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Sara Tomczyk; Nancy M Bennett; Charles Stoecker; Ryan Gierke; Matthew R Moore; Cynthia G Whitney; Stephen Hadler; Tamara Pilishvili
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-19       Impact factor: 17.586
  8 in total
  5 in total

1.  Pneumococcal conjugate vaccine in adults: Let's see what happens.

Authors:  Peter R Paradiso
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 2.  Developing Better Pneumococcal Vaccines for Adults.

Authors:  Daniel M Weinberger; Zitta B Harboe; Eugene D Shapiro
Journal:  JAMA Intern Med       Date:  2017-03-01       Impact factor: 21.873

3.  A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.

Authors:  David Fitz-Patrick; Mariano Young; Daniel A Scott; Ingrid L Scully; Gary Baugher; Yahong Peng; Kathrin U Jansen; William Gruber; Wendy Watson
Journal:  Hum Vaccin Immunother       Date:  2021-02-05       Impact factor: 3.452

4.  Decision-making for PCV in adults.

Authors:  John M McLaughlin; David L Swerdlow; Raul E Isturiz; Luis Jodar
Journal:  Hum Vaccin Immunother       Date:  2018-12-10       Impact factor: 3.452

Review 5.  Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections.

Authors:  Charles Feldman; Ronald Anderson
Journal:  F1000Res       Date:  2020-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.